Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial | BMC Neurology
1,810 followers
10,292 followers
The rationale & design of the Phase IV randomised, double-blind, double-blind OCEAN (OpiCapone Effect on motor fluctuations & pAiN) trial in #Parkinsons has been published, by @KRayChaudhuri1 & colleagues https://t.co/XcxbHh7Dpr https://t.co/7
467 followers
New article: Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor… https://t.co/hd1I2cCU8x #parki
2,499 followers
RT @PaperbirdsM: New article: Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-…